FDA product code SBH: Integrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter

SBH is the FDA product code for integrated continuous glucose monitor for non-intensive glucose management, over-the-counter. It is a Class II device, regulated under 21 CFR 862.1355 and reviewed by the Clinical Chemistry panel. FDA has cleared 3 510(k) submissions under SBH, 3 in the last five years, from 2 different applicants. The average 510(k) review took 98 days (median 84); 119 days on average over the last three years.

Definition

An integrated continuous glucose monitoring system (iCGM) for non-intensive glucose management is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time to detect euglycemic and dysglycemic glucose levels across the range spanning clinically significant hypoglycemia and hyperglycemia levels in persons who are not on insulin and who do not have a significant risk of problematic hypoglycemia. iCGM systems for non-intensive glucose management are designed to reliably and securely transmit glucose measurement data to digitally connected devices, excluding devices intended to control the delivery of insulin, and are intended to be used alone or in conjunction with these digitally connected medical devices.

Classification

FieldValue
Device nameIntegrated Continuous Glucose Monitor For Non-Intensive Glucose Management, Over-The-Counter
Device classClass II
Regulation21 CFR 862.1355
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k)

510(k) clearances per year for SBH

YearClearancesAvg. review days
20241184
2026254

Compare with all 510(k) review times · Search every SBH clearance

Top SBH applicants

ApplicantClearancesLatest
Dexcom, Inc.22026-08-11
Abbott Diabetes Care12024-06-07

Most recent SBH clearances

510(k)ApplicantDeviceDecision dateReview days
K262472Dexcom, Inc.Stelo Glucose Biosensor System2026-08-1125
K260935Dexcom, Inc.Stelo Glucose Biosensor System2026-06-1284
K233861Abbott Diabetes CareLibre Rio Continuous Glucose Monitoring System2024-06-07184

Recalls for SBH devices

FDA recall records list no recalls for product code SBH.

Frequently asked questions

What is FDA product code SBH?

SBH is the FDA product code for integrated continuous glucose monitor for non-intensive glucose management, over-the-counter. It is a Class II device, regulated under 21 CFR 862.1355 and reviewed by the Clinical Chemistry panel.

What device class is SBH?

Class II, regulation 21 CFR 862.1355. Typical premarket route: 510(k).

How long does a 510(k) take for product code SBH?

Across 3 cleared submissions the average was 98 days from receipt to decision (median 84).

Which companies have the most SBH clearances?

Dexcom, Inc. (2); Abbott Diabetes Care (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times